Helsinki, Finland

Anitta H Jarvinen

This inventor holds 1 USPTO granted patent. Top assignee: Orion-Yhtyma Oy. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anitta H Jarvinen. Retrieved from https://idiyas.com/inventor/anitta-h-jarvinen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anitta H Jarvinen: Innovator in Antidepressant Preparation

Introduction

Anitta H Jarvinen is a notable inventor based in Helsinki, Finland. She has made significant contributions to the field of pharmaceuticals, particularly in the preparation of antidepressants. Her innovative work has led to the development of a more efficient process for synthesizing fluoxetine, a widely used antidepressant.

Latest Patents

Anitta holds 1 patent for her invention titled "Process for the preparation of fluoxetine." This patent describes an improved method for synthesizing fluoxetine hydrochloride, which involves simultaneous debenzylation and catalytic hydrogenation of specific compounds. The process utilizes palladium or platinum catalysts under controlled conditions to achieve a high yield of fluoxetine hydrochloride, ranging from 85-87% of the theoretical yield.

Career Highlights

Anitta is currently associated with Orion-yhtyma Oy, a prominent pharmaceutical company in Finland. Her work at Orion has allowed her to focus on innovative drug development, contributing to advancements in mental health treatment.

Collaborations

Anitta has collaborated with esteemed colleagues such as Pekka J Kairisalo and Petri J Hukka. These partnerships have fostered a collaborative environment that enhances research and development efforts within the company.

Conclusion

Anitta H Jarvinen's contributions to the field of pharmaceuticals, particularly in the preparation of fluoxetine, highlight her innovative spirit and dedication to improving mental health treatments. Her work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…